Healthcare Triage: The Acrylamide in Coffee Won’t Give You Cancer, CALIFORNIA

A judge in California recently ruled that coffee would be required to carry a carcinogen warning label, since it contains acrylamide. Well, have the barista make you a double espresso with a shot of evidence, because that coffee probably isn’t going to give you cancer.

This episode was adapted from a column I wrote for The Upshot. Links to sources can be found there.

@aaronecarroll

Hidden information below

Aaron Carroll

Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist and tweets at @aaronecarroll. He is the Chief Health Officer at Indiana University. He is also a Distinguished Professor of Pediatrics and Associate Dean for Research Mentoring at the Indiana University School of Medicine. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.

The Incidental Economist

the health services research blog

Editors In Chief
Managing Editor

Work posted here under copyright © of the authors • Details on the Site Policies page

Subscribe

Email Address*